BCWORLD PHARM. Co. Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

BCWORLD PHARM. Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, BCWORLD PHARM. Co. Ltd (200780) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.43 Billion ≈ $968.52K USD) by net assets (₩72.50 Billion ≈ $49.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of BCWORLD PHARM. Co. Ltd (2015–2024)

Cash flow conversion efficiency of BCWORLD PHARM. Co. Ltd from 2015 to 2024. This chart illustrates how BCWORLD PHARM. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 200780 share price today for real-time trading data and today's change.

BCWORLD PHARM. Co. Ltd Cash Flow Conversion Ratio Explained

BCWORLD PHARM. Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

BCWORLD PHARM. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BCWORLD PHARM. Co. Ltd ranked by their cash flow conversion efficiency. Also see 200780 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Wescoal Holdings Ltd JSE:SLG	-0.815x
Spacenet Enterprises India Limited NSE:SPCENET	0.036x
Tai Twun Enterprise Co Ltd TW:3432	-0.099x
Integral Acquisition 1 Corp NASDAQ:INTE	-0.024x
Jacques Bogart SA PA:JBOG	0.688x
Hannet Co. Ltd KQ:052600	0.057x
Huddlestock Fintech As OL:HUDL	-0.034x
Matricelf Ltd TA:MTLF	-997.589x

Annual Cash Flow Conversion Efficiency for BCWORLD PHARM. Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of BCWORLD PHARM. Co. Ltd from 2015 to 2024. Review BCWORLD PHARM. Co. Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩76.67 Billion ≈ $51.96 Million	₩4.04 Billion ≈ $2.74 Million	0.053x	-60.64%
2023-12-31	₩81.64 Billion ≈ $55.33 Million	₩10.94 Billion ≈ $7.41 Million	0.134x	+54.84%
2022-12-31	₩79.55 Billion ≈ $53.91 Million	₩6.88 Billion ≈ $4.66 Million	0.087x	+1237.07%
2021-12-31	₩81.46 Billion ≈ $55.20 Million	₩-619.83 Million ≈ $-420.05K	-0.008x	+85.94%
2020-12-31	₩101.69 Billion ≈ $68.92 Million	₩-5.50 Billion ≈ $-3.73 Million	-0.054x	-143.45%
2019-12-31	₩97.24 Billion ≈ $65.90 Million	₩12.11 Billion ≈ $8.21 Million	0.125x	+110.10%
2018-12-31	₩90.09 Billion ≈ $61.05 Million	₩5.34 Billion ≈ $3.62 Million	0.059x	-39.05%
2017-12-31	₩81.23 Billion ≈ $55.05 Million	₩7.90 Billion ≈ $5.35 Million	0.097x	+2848.61%
2016-12-31	₩73.88 Billion ≈ $50.06 Million	₩243.66 Million ≈ $165.13K	0.003x	-97.47%
2015-12-31	₩67.40 Billion ≈ $45.68 Million	₩8.78 Billion ≈ $5.95 Million	0.130x	--

About BCWORLD PHARM. Co. Ltd

KQ:200780 Korea Drug Manufacturers - General

Market Cap

$19.40 Million

₩28.63 Billion KRW

Market Cap Rank

#25052 Global

#1831 in Korea

Share Price

₩2800.00

Change (1 day)

-0.36%

52-Week Range

₩2790.00 - ₩5870.00

All Time High

₩30700.49